Dr. McLaughlin conducts a number of clinical research studies related to obesity, insulin resistance, diabetes, and cardiovascular disease. Current studies include:

1. the impact of macronutrient composition on weight loss and cardiocascular risk (diabetic and nondiabetic patients);
2. comparison of weight loss and cardiovascular risk reduction in diabetic patients treated with different classes of antihyperglycemic drugs;
3. the role of the adipocyte in modulating insulin resistance.